High‐titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors
Open Access
- 3 September 2002
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 71 (1) , 33-36
- https://doi.org/10.1002/ajh.10172
Abstract
We report a 79‐year‐old man with two simultaneous malignant tumors (buccal epidermoid carcinoma and prostatic adenocarcinoma) who developed a severe bleeding complication at the site of the buccal tumor as well as a massive cerebral hematoma after a skull trauma. Laboratory findings showed the presence of a high‐titer specific factor V inhibitor. The patient failed to respond to intravenous immunoglobulins, but both clinical and laboratory improvement was obtained after treatment with corticosteroids and cyclophosphamide. Am. J. Hematol. 71:33–36, 2002.Keywords
This publication has 15 references indexed in Scilit:
- Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignanciesAnnals of the Rheumatic Diseases, 2001
- Spontaneous inhibitors to coagulation factorsClinical and Laboratory Haematology, 2000
- Clinical and laboratory manifestations of anti-factor V antibodiesJournal of Laboratory and Clinical Medicine, 1999
- Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell CancerJournal of Clinical Oncology, 1999
- Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.Journal of Clinical Investigation, 1992
- Acquired inhibitors in malignant and nonmalignant disease statesThe American Journal of Medicine, 1991
- Isolation and study of an acquired inhibitor of human coagulation factor V.Journal of Clinical Investigation, 1986
- The response of an acquired Factor V inhibitor to activated Factor IX concentrateTransfusion, 1985
- Factor V anticoagulants: clinical, biochemical, and immunological observationsJournal of Clinical Investigation, 1970